CNS Drug Delivery Innovations Open New Biotech Opportunities as Blood-Brain Barrier Challenges Persist
Oncotelic Therapeutics advances CNS drug delivery with intranasal N2B system for Alzheimer's and biodefense, joining Biogen, Moderna, and CytoDyn in overcoming
2026/05/11